Lv12
30 积分 2024-01-25 加入
Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T‐cells
2小时前
待确认
The potential role of mass spectrometry for the identification and monitoring of patients with plasma cell disorders: Where are we now and which questions remain unanswered?
1天前
已完结
Characterizing M-protein light chain glycosylation via mass spectrometry
1天前
已完结
Screening Method for M-Proteins in Serum Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry
7天前
已完结
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
18天前
已完结
Mutational Landscape and Tumor Burden Assessed by Cell-free DNA in Diffuse Large B-Cell Lymphoma in a Population-Based Study
1个月前
已完结
The Emerging Role of Minimal Residual Disease Testing in Diffuse Large B-Cell Lymphoma
1个月前
已完结
Clinical implications of measurable residual disease in AML: Review of current evidence
3个月前
已完结
The impact of diagnostic wait time on the survival of patients with diffuse large B‐cell lymphoma: effect modification by the International Prognostic Index
4个月前
已完结
Clinical characterization of the mutational landscape of 24,639 real-world samples from patients with myeloid malignancies
6个月前
已完结
皖公网安备34019202002308
